AVNR Key Stats
|Revenue (Quarterly YoY Growth)||87.50%|
|EPS Diluted (TTM)||-0.376|
|EPS Diluted (Quarterly YoY Growth)|
|Net Income (TTM)||-51.75M|
|Gross Profit Margin (Quarterly)||94.55%|
|Profit Margin (Quarterly)||-57.82%|
|Dividend Yield (TTM)||0.00%|
|Payout Ratio (TTM) Pro||Go Pro|
- Most active Nasdaq-traded stocks Dec 6
- Avanir Pharmaceuticals' CEO Presents at 25th Annual Piper Jaffray Health Care Conference (Transcript) Seeking Alpha Dec 4
- 4 Biotech Stocks Under $10 to Watch The Street Dec 4
- Avanir Pharmaceuticals' Management Presents at Deutsche Bank BioFEST Conference (Transcript) Seeking Alpha Dec 3
- Avanir Pharmaceuticals Announces Date of Fiscal 2013 Fourth Quarter Financial Results and Conference Call GlobeNewswire Dec 3
- Avanir Pharmaceuticals to Participate in Two Conferences in December noodls Nov 26
- AVANIR PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Materia Nov 15
- Land This Bargain Even Cheaper Than SVP Palekar Did Nov 11
- Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) noodls Nov 8
- Cramer's Lightning Round - Don't Freak Out About Marketo (10/30/13) Seeking Alpha Oct 31
AVNR Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). AVANIR Pharmaceuticals is up 68.22% over the last year vs S&P 500 Total Return up 30.43%, Impax Laboratories up 13.63%, and Actavis up 89.53%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for AVNR
Pro Report PDF for AVNR
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download AVNR Pro Report PDF
Pro Strategies Featuring AVNR
Did AVANIR Pharmaceuticals make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
Avanir Pharmaceuticals is a pharmaceutical company focused on acquiring, developing and commercializing novel therapeutic products for the treatment of central nervous system disorders.